Clinical trial

Assessing the Risk of Developing Type II Diabetes Using Serum Biomarkers in Patients Diagnosed With Obstructive Sleep Apnea

NCT01447251

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-09-01

PhaseNA

Study timeline

Study start (unknown)2011-09-01Date precision: month

Registry last updated2014-10-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obstructive Sleep Apneaunresolved

Diabetes Mellitusunresolved

Interventions

PreDx Diabetes Risk ScoreBEHAVIORAL

Sponsors & collaborators

Mike O'Callaghan Military Hospitallead sponsor

Mapped research locations

Las VegasNevada, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01447251 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.